Is ProKidney Corp. (PROK) overvalued? · $543.7M cap
ProKidney Corp. (PROK) is a biotechnology company listed on US.
This page asks whether ProKidney Corp. (PROK) looks expensive on cached numbers — not a short thesis.
No cached income statement for PROK, so there is no earnings base to call rich or cheap.
PROK currently screens at market cap $543.7M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next PROK 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the PROK stock page for the full model, not this heading.
Not investment advice.